News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fresenius Kabi AG Recalls Red Blood Cell (RBC) Exchange Sets


12/21/2010 1:05:17 PM

The Company issued a Field Safety Corrective Action letter dated October 18, 2010 to their U.S. customers and followed up with telephone calls advising customers to examine their stock and determine if they have any affected products on hand. Customers were instructed to discontinue distributing, using, and dispensing the affected products, and return the product to Fresenius Kabi, LLC, 8635 154th Avenue, NE, Redmond, WA 98052. The consignees/customers were also instructed to notify their sub-account customers if the products were further distributed and to complete the Product Recall Response Form and fax it back to 425-242-2101.

Read at FDA


comments powered by Disqus
FDA
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES